GGrantIndex
Sort

50,496 grants matching lung cancer

Project 1: Systematic Physical and Spatial Mapping of Cancer Driver Networks

$561,871
Emma Lundberg · University Of California, San Francisco · U54 · FY2022 · CA

Medical Care Burden of Cancer: System and Data Issues

$561,821
Mark Christopher Hornbrook · Kaiser Foundation Research Institute · R01 · FY2010 · CA

15-Hydroxyprostaglandin Dehydrogenase, NSAIDs, Vitamin D, and Coloretcal Neoplasi

$561,786
Li Li · Case Western Reserve University · U01 · FY2014 · CA

Prostate Cancer Diagnosis by Multiparametric Ultrasound

$561,765
Flemming Forsberg · Thomas Jefferson University · R01 · FY2023 · CA

Improving the Timeliness and Quality of Care for Rural Lung and Head-and-Neck Cancer Patients

$561,761
Evelinn Borrayo · University Of Colorado Denver · R01 · FY2021 · CA

A deubiquitination module controls Treg adaptation to tumor microenvironment

$561,629
Deyu Fang · Northwestern University At Chicago · R01 · FY2021 · CA

A new imaging approach to radiotherapy planning for lung cancer

$561,557
Rahim R Rizi · University Of Pennsylvania · R01 · FY2019 · CA

Harnessing the CRL4 ubiquitin ligase for antagonizing colorectal carcinogenesis

$561,496
Pengbo Zhou · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · CA

Develop novel bispecific antibody-drug conjugates against metastatic lethal prostate cancer across subtype

$561,495
Bin Liu · University Of California, San Francisco · R01 · FY2025 · CA

Genetic Determinants of Tumor Growth and Drug Sensitivity in EGFR Mutant Lung Cancer

$561,463
Katerina Abigail Politi · Yale University · R01 · FY2022 · CA

Immunotoxicity of Workplace Xenobiotics

$561,364
National Institute Of Environmental Health Sciences · Y01 · FY2009 · ES

Quantitative Multiscale Imaging to Optimize Cancer Treatment Strategies

$561,337
Vito Quaranta · Vanderbilt University · R01 · FY2019 · CA

Risk Factors for Sepsis in the Community

$561,301
Henry E Wang · University Of Alabama At Birmingham · R01 · FY2011 · NR

Development of FISH Molecular Diagnostics to support Clinical Trials at NCI

$561,216
Svetlana Pack · Division Of Basic Sciences - Nci · ZID · FY2014 · CA

Genomic and Functional Identification of Chemotherapy Resistance Mechanisms in Small Cell Lung Cancer

$561,139
Ramaswamy Govindan · Washington University · U01 · FY2021 · CA

MicroFlex Technology for Early Detection of Lung Disease

$561,069
Dale A. Lawrence · Quest Product Development Corporation · R42 · FY2013 · HL

DCTD Preclinical In Vivo/In Vitro Assay Development

$561,055
David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2013 · CA

Squamous Cell Carcinoma of the Lung: Validation of Molecular Signatures for Progn

$561,038
Fred R Hirsch · University Of Colorado Denver · U01 · FY2013 · CA

Comprehensive molecular characterization of lung cancers in five racial/ethnic groups with disparate risk

$561,035
Sungshim Lani Park · University Of Hawaii At Manoa · R01 · FY2020 · MD

Signal Transduction by Non-transmembrane PTPs

$561,026
Beth Israel Deaconess Medical Center · R37 · FY2005 · CA

Developmental Funds

$560,871
Jennifer A Pietenpol · Vanderbilt University · P30 · FY2013 · CA

Biomarkers of toxic response to low nicotine cigarette smoke

$560,864
Ian Alexander Blair · University Of Pennsylvania · R01 · FY2012 · CA

Supplemental Se and Vitamin E and Pulmonary Function

$560,835
Patricia A Cassano · Cornell University · R01 · FY2007 · HL

Development of novel selective Rac inhibitors for refractory leukemias

$560,804
David A Williams · Boston Children'S Hospital · R01 · FY2018 · CA

Genomic and Functional Identification of Chemotherapy Resistance Mechanisms in Small Cell Lung Cancer

$560,803
Ramaswamy Govindan · Washington University · U01 · FY2019 · CA